120 related articles for article (PubMed ID: 6691733)
1. Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy.
Dardik H; Ibrahim IM; Sussman B; Kahn M; Sanchez M; Klausner S; Baier RE; Meyer AE; Dardik II
Ann Surg; 1984 Jan; 199(1):61-8. PubMed ID: 6691733
[TBL] [Abstract][Full Text] [Related]
2. Biodegradation of glutaraldehyde-tanned human umbilical vein grafts.
Sato O; Okamoto H; Takagi A; Miyata T; Takayama Y
Surg Today; 1995; 25(10):901-5. PubMed ID: 8574057
[TBL] [Abstract][Full Text] [Related]
3. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb.
Dardik H; Miller N; Dardik A; Ibrahim I; Sussman B; Berry SM; Wolodiger F; Kahn M; Dardik I
J Vasc Surg; 1988 Feb; 7(2):336-46. PubMed ID: 3123718
[TBL] [Abstract][Full Text] [Related]
4. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases.
Dardik H; Wengerter K; Qin F; Pangilinan A; Silvestri F; Wolodiger F; Kahn M; Sussman B; Ibrahim IM
J Vasc Surg; 2002 Jan; 35(1):64-71. PubMed ID: 11802134
[TBL] [Abstract][Full Text] [Related]
5. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
[TBL] [Abstract][Full Text] [Related]
6. Aneurysm formation in human umbilical vein grafts used as arterial substitutes.
Boontje AH
J Vasc Surg; 1985 Jul; 2(4):524-9. PubMed ID: 4009832
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathologic study of aneurysm formation of glutaraldehyde-tanned human umbilical vein grafts.
Miyata T; Tada Y; Takagi A; Sato O; Oshima A; Idezuki Y; Shiga J
J Vasc Surg; 1989 Dec; 10(6):605-11. PubMed ID: 2585648
[TBL] [Abstract][Full Text] [Related]
8. Prediction of aneurysm formation in vascular grafts of biologic origin.
Hamilton G; Megerman J; L'Italien GJ; Warnock DF; Schmitz-Rixen T; Brewster DC; Abbott WM
J Vasc Surg; 1988 Mar; 7(3):400-8. PubMed ID: 2831410
[TBL] [Abstract][Full Text] [Related]
9. Infrapopliteal composite bypass with autologous vein and second generation glutaraldehyde stabilized human umbilical vein (HUV) for critical lower limb ischaemia.
Neufang A; Espinola-Klein C; Dorweiler B; Savvidis S; Schmiedt W; Vahl CF
Eur J Vasc Endovasc Surg; 2007 Nov; 34(5):583-9. PubMed ID: 17574877
[TBL] [Abstract][Full Text] [Related]
10. Glutaraldehyde-stabilized umbilical vein prosthesis for revascularization of the legs. Three year results by life table analysis.
Dardik H; Ibrahim IM; Sussman B; Jarrah M; Dardik II
Am J Surg; 1979 Aug; 138(2):234-7. PubMed ID: 464221
[No Abstract] [Full Text] [Related]
11. Biogenic grafts in arterial surgery--long-term results (I. The homologous vein--II. The modified heterologous bovine carotid artery--III. The human umbilical vein).
Sciacca V; Walter G; Becker HM
Thorac Cardiovasc Surg; 1984 Jun; 32(3):157-64. PubMed ID: 6206595
[TBL] [Abstract][Full Text] [Related]
12. Aneurysm formation in modified human umbilical vein grafts.
Strobel R; Boontje AH; Van Den Dungen JJ
Eur J Vasc Endovasc Surg; 1996 May; 11(4):417-20. PubMed ID: 8846174
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical vein grafts as infrainguinal bypasses: long-term clinical follow-up and pathological investigation of explanted grafts.
Batt M; Gagliardi JM; Avril G; Guzman R; Guidoin R; Hassen-Khodja R; Marois M; Le Bas P
Clin Invest Med; 1990 Aug; 13(4):155-64. PubMed ID: 2208831
[TBL] [Abstract][Full Text] [Related]
14. Glutaraldehyde pre-treated human saphenous and umbilical veins as xenogeneic small vessel substitutes and shunts in dogs.
Harjula A
Ann Chir Gynaecol; 1981; 70(1):11-7. PubMed ID: 7259055
[TBL] [Abstract][Full Text] [Related]
15. Experiences with Meadox-Dardik umbilical vein biograft as a lower extremity bypass graft.
Sharf AG
Int Surg; 1978; 63(5):37-40. PubMed ID: 730472
[TBL] [Abstract][Full Text] [Related]
16. Successful arterial substitution with modified human umbilical vein.
Dardik H; Dardik II
Ann Surg; 1976 Mar; 183(3):252-8. PubMed ID: 816263
[TBL] [Abstract][Full Text] [Related]
17. An histo-morphological evaluation of ninety surgically excised human umbilical vein grafts.
Gill F; Guzman R; Guidoin R; Avril G; Charara J; Batt M; Roy PE; Marois M; Graham AM; Symes JF
J Biomed Mater Res; 1989 Dec; 23(A3 Suppl):363-80. PubMed ID: 2613744
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord vein as arterial substitute in the dog.
Karvonen E; Harjula A; Meurala H; Harjola PT
Ann Chir Gynaecol; 1981; 70(2):61-4. PubMed ID: 6459050
[TBL] [Abstract][Full Text] [Related]
19. Extended study of aneurysm formation in umbilical vein grafts.
Karkow WS; Cranley JJ; Cranley RD; Hafner CD; Ruoff BA
J Vasc Surg; 1986 Nov; 4(5):486-92. PubMed ID: 2945935
[TBL] [Abstract][Full Text] [Related]
20. Sequential femorodistal composite bypass with second generation glutaraldehyde stabilized human umbilical vein (HUV).
Neufang A; Espinola-Klein C; Dorweiler B; Reinstadler J; Pitton M; Savvidis S; Fischer R; Vahl C; Schmiedt W
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):176-83. PubMed ID: 15950502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
